Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan

Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 226; no. 11; pp. 2038 - 2039
Main Authors: Amano, Masayuki, Maeda, Kenji, Tsuchiya, Kiyoto, Shimada, Shinya, Mitsuya, Hiroaki
Format: Journal Article
Language:English
Published: United States 28-11-2022
Subjects:
Antibodies, Neutralizing
Antibodies, Viral
BNT162 Vaccine
COVID-19 - prevention & control
Humans
Japan
SARS-CoV-2
Vaccination
Japan
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ObjectType-Article-3
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiac209